title: Management of chronic hepatitis C: consensus guidelines.
abstract: Since the last consensus conference on the management of chronic viral hepatitis, a number of studies looking at modifications of the standard course of treatment have been published. These changes have been sufficiently substantive to warrant review to determine whether any changes in the recommended treatment algorithms are needed. A consensus development conference was held in January 2007, and the present document highlights the results of the presentations and discussion about these issues. It reviews the epidemiology of hepatitis C in Canada, treatment of acute hepatitis C and new algorithms in chronic hepatitis C, including retreatment of previous treatment failures. In addition, sections on management of hepatitis C in special populations have been updated. There is also a section on the use of hematopoietic growth factors to help manage patients on therapy. The document should be read in conjunction with the previous document to identify changes. Some recommendations made in the previous document remain and are not discussed here.
authors.affiliation: Department of Medicine, University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada. morris.sherman@uhn.on.ca
authors.forename: Morris
authors.initials: M
authors.lastname: Sherman
authors.forename: Stephen
authors.initials: S
authors.lastname: Shafran
authors.forename: Kelly
authors.initials: K
authors.lastname: Burak
authors.forename: Karen
authors.initials: K
authors.lastname: Doucette
authors.forename: Winnie
authors.initials: W
authors.lastname: Wong
authors.forename: Nigel
authors.initials: N
authors.lastname: Girgrah
authors.forename: Eric
authors.initials: E
authors.lastname: Yoshida
authors.forename: Eberhard
authors.initials: E
authors.lastname: Renner
authors.forename: Philip
authors.initials: P
authors.lastname: Wong
authors.forename: Marc
authors.initials: M
authors.lastname: Deschênes
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002170:Canada; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D000998:Antiviral Agents